Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03810066
Brief Title: Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS)

First Submitted : January 10, 2019
First Submitted that Met QC Criteria : January 17, 2019
First Posted : January 18, 2019

Last Update Submitted that Met QC Criteria : July 16, 2019
Last Update Posted : July 17, 2019